Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 4
1964 6
1965 6
1966 6
1967 5
1968 10
1969 20
1970 17
1971 15
1972 29
1973 25
1974 26
1975 18
1976 12
1977 30
1978 34
1979 24
1980 29
1981 28
1982 28
1983 44
1984 49
1985 32
1986 30
1987 49
1988 60
1989 96
1990 94
1991 102
1992 126
1993 110
1994 188
1995 177
1996 192
1997 246
1998 252
1999 308
2000 340
2001 360
2002 379
2003 425
2004 495
2005 548
2006 556
2007 651
2008 657
2009 602
2010 676
2011 707
2012 781
2013 923
2014 986
2015 1055
2016 1095
2017 1121
2018 1155
2019 1197
2020 1316
2021 1558
2022 1523
2023 1381
2024 544

Text availability

Article attribute

Article type

Publication date

Search Results

10,870 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Multiple sclerosis, a treatable disease.
Doshi A, Chataway J. Doshi A, et al. Clin Med (Lond). 2016 Dec;16(Suppl 6):s53-s59. doi: 10.7861/clinmedicine.16-6-s53. Clin Med (Lond). 2016. PMID: 27956442 Free PMC article. Review.
This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. ...
This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition re …
Multiple Sclerosis.
Olek MJ. Olek MJ. Ann Intern Med. 2021 Jun;174(6):ITC81-ITC96. doi: 10.7326/AITC202106150. Epub 2021 Jun 8. Ann Intern Med. 2021. PMID: 34097429 Review.
Food and Drug Administration has approved 7 new medications for relapsing-remitting multiple sclerosis and approved the first medication for primary progressive multiple sclerosis. ...Also, new medications for treating the symptoms of multiple …
Food and Drug Administration has approved 7 new medications for relapsing-remitting multiple sclerosis and approved the first …
Multiple sclerosis: clinical aspects.
Oh J, Vidal-Jordana A, Montalban X. Oh J, et al. Curr Opin Neurol. 2018 Dec;31(6):752-759. doi: 10.1097/WCO.0000000000000622. Curr Opin Neurol. 2018. PMID: 30300239 Review.
RECENT FINDINGS: Multiple sclerosis is increasing in incidence and prevalence globally, even in traditionally low-prevalence regions of the world. ...SUMMARY: A number of recent advances have been made in the clinical diagnosis and prognostication of multiple …
RECENT FINDINGS: Multiple sclerosis is increasing in incidence and prevalence globally, even in traditionally low-prevalence r …
Multiple sclerosis - a review.
Dobson R, Giovannoni G. Dobson R, et al. Eur J Neurol. 2019 Jan;26(1):27-40. doi: 10.1111/ene.13819. Epub 2018 Nov 18. Eur J Neurol. 2019. PMID: 30300457 Review.
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. ...
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. ...
Multiple sclerosis.
Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Thompson AJ, et al. Lancet. 2018 Apr 21;391(10130):1622-1636. doi: 10.1016/S0140-6736(18)30481-1. Epub 2018 Mar 23. Lancet. 2018. PMID: 29576504 Free article. Review.
Multiple sclerosis continues to be a challenging and disabling condition but there is now greater understanding of the underlying genetic and environmental factors that drive the condition, including low vitamin D levels, cigarette smoking, and obesity. ...The great …
Multiple sclerosis continues to be a challenging and disabling condition but there is now greater understanding of the underly …
Multiple sclerosis.
Cotsapas C, Mitrovic M, Hafler D. Cotsapas C, et al. Handb Clin Neurol. 2018;148:723-730. doi: 10.1016/B978-0-444-64076-5.00046-6. Handb Clin Neurol. 2018. PMID: 29478610 Free article. Review.
Multiple sclerosis is a potentially progressive, autoimmune neurologic disorder of the central nervous system, resulting from an autoimmune attack on central nervous system white matter. ...Finally, we discuss how these results are revealing the specific pathobiolog …
Multiple sclerosis is a potentially progressive, autoimmune neurologic disorder of the central nervous system, resulting from …
Multiple Sclerosis.
Yamout BI, Alroughani R. Yamout BI, et al. Semin Neurol. 2018 Apr;38(2):212-225. doi: 10.1055/s-0038-1649502. Epub 2018 May 23. Semin Neurol. 2018. PMID: 29791948 Free article. Review.
Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease of autoimmune etiology, mediated by activated T cells with evolving evidence of a significant contribution from B cells and cells of the innate immune system. ...
Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease of autoimmune etiology, mediated by activated …
Multiple sclerosis - etiology and diagnostic potential.
Kamińska J, Koper OM, Piechal K, Kemona H. Kamińska J, et al. Postepy Hig Med Dosw (Online). 2017 Jun 30;71(0):551-563. doi: 10.5604/01.3001.0010.3836. Postepy Hig Med Dosw (Online). 2017. PMID: 28665284 Free article. Review.
Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of autoimmune originate. ...Among clinical courses of MS it can be distinguish relapsing-remitting multiple sclerosis (RRMS), secondary progressive multiple sclerosis …
Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of autoimmune originate. ...Among clinical courses …
Multiple Sclerosis.
Reich DS, Lucchinetti CF, Calabresi PA. Reich DS, et al. N Engl J Med. 2018 Jan 11;378(2):169-180. doi: 10.1056/NEJMra1401483. N Engl J Med. 2018. PMID: 29320652 Free PMC article. Review. No abstract available.
Updates and advances in multiple sclerosis neurotherapeutics.
Amin M, Hersh CM. Amin M, et al. Neurodegener Dis Manag. 2023 Feb;13(1):47-70. doi: 10.2217/nmt-2021-0058. Epub 2022 Oct 31. Neurodegener Dis Manag. 2023. PMID: 36314777 Free PMC article. Review.
The multiple sclerosis (MS) neurotherapeutic landscape is rapidly evolving. ...This review provides a summary of these updates. The range of treatment options available for multiple sclerosis (MS) is growing, with the aim of developing safer and more e …
The multiple sclerosis (MS) neurotherapeutic landscape is rapidly evolving. ...This review provides a summary of these updates …
10,870 results
You have reached the last available page of results. Please see the User Guide for more information.